Bioaccessibility-based risk assessment of PAHs in soils from sites of different anthropogenic activities in Lagos, Nigeria using the fed organic estimation human simulation test method by Adetunde, Oluwatoyin T. et al.
1 
 
Bio-accessibility based risk assessment of PAHs in soils from sites of different anthropogenic 
activities in Lagos, Nigeria using the Fed Organic Estimation Human Simulation Test method 
 
Oluwatoyin T. Adetundea, Graham A. Millsb*, Kehinde O. Olayinkaa, Babajide I. Aloa 
aDepartment of Chemistry, Faculty of Science, University of Lagos, Akoka, Yaba, Lagos, Nigeria  
bSchool of Pharmacy and Biomedical Science, University of Portsmouth, Portsmouth, PO1 2DT, 
United Kingdom 
 
*Corresponding author:  
E-mail: graham.mills@port.ac.uk 
Tel.: 00 44(0) 23 9284 2115  
Abstract 
The aim of this study was to carry out a bio-accessibility based risk assessment of polycyclic 
aromatic hydrocarbon (PAHs) in soils from sites of different anthropogenic activities in Lagos, 
Nigeria. Using an in vitro gastrointestinal model – Fed Organic Estimation Human Simulation Test 
method (FOREShT)), the concentration of bio-accessible 16 priority US Environmental Protection 
Agency (USEPA) PAHs in soils were determined. Total concentration of 16 priority USEPA PAHs 
was also determined. The concentration range was 702 to 253,922 ng g-1 and 92-760 ng g-1 for total 
and bio-accessible PAHs respectively. For persons involved with activities at these sites no health 
risk were observed, based on bio-accessibility values of PAHs. Mean daily intake of PAHs from 
these soils were below the oral mean daily intake threshold for PAHs in food. Also, overall 
estimated theoretical cancer risk (2.5 × 10-09, 6.5 × 10-07, 5.5 × 10-10, 2.7 × 10-09, 6.5 × 10-10, 9.5 × 
10-10, 2.0 × 10-09 and 4.1 × 10-07 for the eight sites based on their bio-accessible concentration) for 
exposure to PAHs in surface soils were below the health guidelines for extreme (1 × 10-04) and 
normal (1 × 10-06) exposures.  
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INTRODUCTION 
Polycyclic aromatic hydrocarbons (PAHs) are widely distributed in the environment. Human 
activities such as refining of petroleum, burning of fossil fuels, oil spills and open incineration of 
waste among others have contributed significantly to the PAHs concentrations in the environment. 
PAHs are semi-volatile, hydrophobic organic compounds covering a wide range of molecular 
weights. Hence they can be deposited onto soil, plant surfaces and water bodies (Li et al.  2009; 
Abdel-Shafy and Mansour, 2016, Lawal & Fantke, 2017). Soil PAHs, when taken up by plants 
roots bio-accumulate. Plant PAHs are transferred to other organisms by ingestion; often reaching 
concentrations that can cause toxicological effects (e.g. cellular mutations) (Manoli et al.  2004). 
Human exposure to PAHs occurs via various routes such as ingestion of contaminated food, 
inhalation of contaminated air and dusts, or dermal contact with contaminated media (Hussein et al.  
2016; Kim et al.  2009; Oomen et al.  2003; USEPA, 2008a; USEPA, 2008b). Concentration of 
PAHs in soils are significantly associated with their corresponding concentrations in air, household, 
urban street dusts which have far reaching agricultural, environmental and human health effects. 
The concentration of PAHs in soil is a good indicator of the overall degree of environmental 
pollution (Adetunde et al.  2014). Therefore, contaminant levels in soils are of concern to regulatory 
agencies in most countries. 
Exposure to the ‘total’ concentration of a chemical (estimated using exhaustive extraction 
procedures such as ultra-sonication or Soxhlet) in soil is often used as the basis of risk assessments 
e.g. the overall estimated theoretical cancer risk (ER), mean dietary intake (MDI), or 
benzo(a)pyrene equivalence dose (BaPeq). This approach, however, can lead to overestimation of 
any risk, since only a fraction of the total concentration of the chemical is absorbed into the 
systemic circulation (Adetunde et al.  2014; Gomez-Eyles et al.  2010; Turkall et al.  2009). The 
most important factor in predicting or assessing the health risk of lipophilic organic chemicals, such 
as PAHs, is the bio-available and bio-accessible fractions (Tao et al.  2009). 
There have been attempts to measure both the bio-availability and bio-accessibility of 
pollutants using in vivo procedures, but these have limitations because of ethical issues, disparities 
between human and animal absorption systems (Intawongse and Dean, 2006). In-vitro assessment 
may overcome some of these limitations. The Fed Organic Estimation Human Simulation Test 
(FOREShT) a standardized in vitro bio-accessibility test for organic pollutants in soils was 
developed by members of Bio-accessibility Research Group Europe (BARGE) as a follow-on from 
the Unified Barge Method used for inorganic contaminants (Cave et al.  2010).  
Knowledge of the bio-availability/bio-accessibility of a pollutant is important for risk 
assessments especially in risk based clean-up when a level of remediation is to be determined 
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(Liptak and Lombardo, 1996; Zia et al.  2011). The degree of any risk-based clean-up of a 
contaminant in the environment increases with its decreasing bio-availability. That is the limiting 
values are high if the contaminant is not bio-assessable and low limits are used if the contaminant is 
bio-accessible (Rostami and Juhasz, 2011; Wan-ling et al.  2011; Zia et al.  2011). 
Lagos, the fastest growing city in Nigeria, is one of the largest and most densely populated 
city in Africa. It is situated on the South-Western Coast of Nigeria and approximately 60% of 
Nigeria’s industrial and commercial activities are situated here (Ajibola et al.  2012; MoELS, 2010). 
Thus the land of Lagos over the years has been put to many uses including industrial. The 
increasing population of Lagos state has also led to an increase in the demand for land and to meet 
this demand reclamation of swamps, former industrial sites and dumpsites are on the rise. Hence, 
the need for site specific risk assessment of such sites. Bio-accessibility is highly site and source-
specific, insufficient data usually makes it difficult to adequately define a value that differs from the 
default approach of 100%. A site-specific assessment of bio-accessibility can be undertaken to carry 
out risk assessment (Hansen et al. , 2007).  
In Nigeria information on the concentration and distribution pattern of PAHs in soils within 
the country is lacking. This information is important for regulators in order to make valid hazard 
and risk assessments. We undertook a study to assess occupational exposure to PAHs via 
involuntary ingestion of soil from different sites around the city of Lagos (Adetunde et al.  2014). 
Assessment was based on the total 16 PAHs on the USEPA’s priority list. The aim of this follow-on 
study was to measure the bio-accessible PAHs at these locations and use it to evaluate of risk 
associated with bio-accessible PAHs present. This preliminary information will be beneficial to 
Nigerian agencies who are tasked with undertaking environmental health assessments.  
 
MATERIALAND METHODS 
Sampling 
Six sub-samples of surface soil (collected at a depth 0-10 cm) were obtained from eight 
locations (A-H) associated with different anthropogenic activities in Lagos, Nigeria (Fig. 1). 
Samples were collected during April, 2011 corresponding to the rainy season with ambient 
temperatures ranging typically between 18-30oC. A composite sample for analysis from each site 
was made by thoroughly mixing the sub-samples followed by sieving (2 mm mesh size). The eight 
soil samples were classified as A = dark grey sandy/ clayey, B = dark grey sandy/clayey, C = dark 
brown sandy/silty, D = dark brown sandy/ silty, E= oily black sandy/clayey, F = sandy/gravel, G = 
grey sandy/silty and H= dark black oily sandy/clayey types.   
4 
 
Chemicals and Standards 
A mixture of 16 USEPA PAHs (all 2,000 μg mL-1) was obtained from Supelco (Bellefonte, 
PA, USA). The components of the mixture were naphthalene (NAP), 1-methylnaphthalene (1-
MNAP), 2-methylnaphthalene (2-MNAP), acenaphthylene (ACY), acenaphthene (ACP), fluorene 
(FLR), phenanthrene (PHE), anthracene (ANT), fluoranthene (FLT), pyrene (PYR), 
benzo[a]anthracene (BaA), chrysene (CHR), benzo[b]fluoranthene (BbF), benzo[k]fluoranthene 
(BkF), benzo[a]pyrene (BaP), indeno[1,2,3-cd]pyrene (IcP), dibenzo[a,h]anthracene (DaH) and 
benzo[g,h,i]perylene (BgP). Deuterated PAHs were used as internal standards. The deuterated 
internal standard solution (all 2,000 μg mL-1 in dichloromethane) contained d10-acenaphthene, d8-
naphthalene, d10-phenanthrene, d12-chrysene, d12-perylene and d4-1,4-dichlorobenzene (Supelco). 
The certified reference material CRM 172-100G for USEPA PAHs used for method validation was 
from Supelco. HPLC grade solvents were purchased from Fisher Scientific Ltd. (Loughborough, 
UK). Gut enzymes (α-amylase (activity: 1,000-3,000 units/mg protein), pepsin (activity: 2,500 
units/mg protein), pepsin from porcine gastric mucosa (activity: 3,200-4,500 units/mg protein), 
pancreatin and lipase) and reagents for the bio-accessibility study where from Supelco Ltd. and 
Fisher Scientific Ltd. 
 
Extraction, Clean-up and Analysis of PAHs 
Extraction, clean up and analysis of PAHs were carried out as in Adetunde et al (2104). 
Briefly PAHs from 0.5–5 g soil and the CRM 172-100G (1 g) were extracted ultrasonically using 
three sequential extractions of acetone: n-hexane (1:1 v/v). The combined extract (25 mL) was 
spiked with internal standard solution (25 µL of 10 mg mL-1) and concentrated under nitrogen to 
500 µL. C18 Bond Elut (200 mg, 5 mL) cartridges were used for clean–up. Cartridges were pre-
conditioned, concentrated extracts were loaded on them and eluted with dichloromethane: n-hexane 
(1:1 v/v, 5 mL) at a flow rate of 1 mL min-1. Eluates were evaporated to dryness under nitrogen and 
reconstituted in n-hexane (1 mL). Working standard solutions were prepared daily in n-hexane. An 
Agilent GC/MS (6890N GC) equipped with split/splitless injector, with a HP-5MS UI capillary 
column (30 m long, 0.25 mm i.d. × 0.25 µm film thickness) connected to a mass selective detector 
(Agilent 5975) was used to separate and quantify the PAHs. Samples were injected (2 µL) in the 
splitless mode at an injection temperature of 290 0C. The column oven was held at 50 0C (3.2 min), 
raised to 150 0C (300C min-1), then raised to 2380C (20C min-1), 2720C (3oC min-1) and to 3000C 
(700C/min and held for 2.73 min). Helium was used as carrier gas at a constant flow rate (1 
mL/min). Mass spectra were acquired using electron ionization (EI) at 70 eV. Identification of 
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PAHs was by confirmation of retention time and abundance of quantification/confirmation ions 
compared to authentic standards. Compounds were quantified using selective ion monitoring (SIM). 
The analytical samples series comprised the CRM, one standard treated similarly to the samples (to 
determine recoveries), a blank and six standards for calibration (Marce and Borrull, 2000; Oluseyi 
et al.  2011; Silva et al.  2011). Internal standard calibration using the response factors of individual 
PAHs related to the respective internal standards based on six-point calibration curve were used to 
quantify individual compounds in the soils.  
 
Measurement of Bio-accessible PAHs  
The extraction of bio-accessible PAHs present in soil samples was undertaken by using the 
FOREhST method developed by BARGE (Cave et al.  2010; Lorenzi et al.  2012) with 
modifications at the clean-up step. The procedure involved three stages and was carried at 37 0C 
utilizing an end-to-end rotator to simulate human bowel movements. At the first stage, 
gastrointestinal fluids namely saliva (pH: 6.8 ± 0.5), gastric (pH: 1.3 ± 0.5), duodenal (pH: 8.1 ± 
0.2) and bile fluids (pH: 8.2 ± 0.2) were simulated using gut enzymes, mucin salts and urea. At the 
second stage gastrointestinal fluids were used to extract the bio-accessible PAHs.  Test soil sample 
(0.3 g), food (organic cream porridge, from HiPP UK Ltd., Newbury, UK), water and oil (sunflower 
oil, from ASDA Stores Ltd., Leeds, UK) were placed in amber bottles and extracted by adding 
gastrointestinal fluids one by one. To simulate the mouth, saliva was put in the food mixture for 5 
mins. Gastric phase was simulated by adding gastric juice to the mixture from mouth phase and 
allowing it to rotate for 2 h. The intestinal phase was simulated by adding duodenal and bile fluids 
to derived gastric phase mixture. The intestinal phase was left to mix for 2 h. Fluid ratio for 
saliva:gastric:duodenal:bile was 1:2:2:1 v/v/v/v in at the end of the test. Saponification is the last 
step which is an extra isolation stage that helps to facilitate the complete extraction of PAHs from 
the complex food and enzymatic juice mixture.  The resultant mixture was centrifuged at 3,000 rpm 
for 5 min. An aliquot (1 mL) of supernatant was removed into a heat resistant glass vial for 
saponification (3 mL of KOH (5.6 M) in methanol for 1 h at 100 0C).  
Extraction and quantification of bio-accessible PAHs was carried out after extracts were left 
to cool. The extracts were diluted with water (6 mL) and leaned-up on a pre-conditioned C18 Bond 
Elut SPE cartridge (200 mg, 5 mL). The elution was performed by dichloromethane (5 mL). Eluents 
were concentrated to dryness under nitrogen, then reconstituted in n-hexane (500 µL). 
Concentration of the bio-accessible PAHs was measured using the GC/MS-SIM method as 
described above. Extractions were carried out in triplicate. A blank extraction was also carried out. 
Spiked blanks were used for recovery studies of PAHs in the bio-accessibility study.  
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Risk Assessment  
           Health-risk posed by exposure to PAHs was determined using the quantified bio-accessible 
PAHs. Carcinogenic potency of PAHs relative to BaP was calculated as given by Tsai et al.  (2001) 
using the TEFs developed by Nisbet and LaGoy (1992). Xia et al.  (2010) and Boström et al.  
(2002) sugguested these TEF were better risk indicators. BaPeq dose was calculated as follows: 
BaPeq dose (µg g-1) = TEF x concentration (µg g-1) (Huang et al.  2005), Sum BaPeq dose (µg g-1) = 
∑(TEF x concentration (µg g-1)). 
               Mean daily intake (MDI) concentrations, annual daily exposure dose (Da) and estimated 
theoretical cancer risk (ER) from exposure to contaminants were calculated as in Adetunde et al.  
(2014), Davoli et al.  (2010) and Lorenzi et al.  (2011) but bio-accessible PAHs fractions were  used 
in this calculations since it is this fraction that causes the actual risk.  
              Briefly, Da (µg kg-1 day-1) = [EC × SIR]/BW based on daily exposure and MDI is like D 
but without BW taken into account.  Where BW= body weight of adult (70 kg) (ATSDR, 2005; 
USEPA, 2011), SIR = soil ingestion rate for adult (0.10 g day-1) (ATSDR, 2005), EC = exposure 
concentration of PAHs (µg g-1). The annual daily exposure dose (Da) also called the average life 
time daily exposure or estimated exposure dose and is calculated from D. 
Da was estimated for workers on these sites based on 246 work days a year. This was arrived 
at by considering 52 weeks in a year. The 15 days of public holidays per year in Nigeria and 2 
weekend days (Saturday and Sunday) a week when workers usually do not go to work were also 
considered. The nature of work undertaken at these sites is unstructured so leave from work was not 
considered in this assumption. Working hours were taken as 8 h day-1. It was assumed that a person 
will work for 40 years (25-65 years of age) at these sites. The default value for bio-accessibility and 
bio-availability in calculation of Da is one when the study on availability or accessibility study is 
not carried out.  A value of one assumes that all of the PAHs to which the workers on site are orally 
exposed to solubilises in the guts (bio-accessibility) or is absorbed from the guts (bio-
availability)(ATSDR, 2005) but since bio-accessibility was carried the default value of one was not 
used. AF = bio-accessibility factor, was used in calculating Da. 
The estimated theoretical cancer risk (ER) from exposure to contaminants was calculated by 
multiplying the estimated exposure dose by the cancer slope factor (CSF) for a suspected or known 
carcinogenic substance (ODH, 2011). Where ER = CSF × estimated exposure dose (mg kg-1day-1) 
and CSF = (7.3 (mg kg-1day-1)-1) (Nyarko et al.  2011, ODH, 2011).  
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RESULTS AND DISCUSSION 
Concentration of PAHs in Soil 
The sum of concentrations of the PAHs in the different soils ranged between 702-253,922 ng g-1. 
Heavily contaminated soils are defined as those where the total concentration of PAHs is > 1,000 ng 
g-1, contaminated soils 600-1,000 ng g-1, weakly contaminated soils 200-600 ng g-1 and non-
contaminated < 200 ng/g (Maliszewska-Kordybach, 2005). Using these definitions, soil from sites 
A, B, D, E, F and H were classified as heavily contaminated, and sites C and G as contaminated 
(Table 1). The very high concentrations of PAHs (~254,000 ng g-1) found at site E were associated 
with its long time use as a kerosene and petrol loading station.  
Analytical performance of FOREShT procedure for bio-accessibility test 
In order to test the effectiveness C18 Bond Elut SPE cartridges in extracting the PAHs from the 
saponified extract, recovery experiments were carried out. The standard USEPA PAHs mixture was 
spiked into the diluted saponifcation medium (such that each of the individual USEPA PAHs had a 
concentration of 5,000 ng mL-1), applied to the SPE cartridge and then eluted with dichloromethane 
(5 mL). The results are shown in Fig. 2. As expected lower recoveries were found for the more 
volatile compounds (i.e. naphthalene, acenaphthylene, acenaphthene, fluorene) in this multi-step 
clean-up method; as has been observed by other workers using the FOREShT  procedure (Lorenzi 
et al.  2012). Generally, this overall analytical method was considered acceptable; typically with 
accuracy (% recoveries between 70% and 130%) and precision (relative standard deviation < 30%) 
in accordance with USEPA criteria for the quality control and validation of analytical methods 
(USEPA, 1992).  
 
Bio-accessibility of PAHs in soils 
Bio-accessibility (using the in vitro FOREShT model) was assessed by measuring the orally 
accessible PAHs to the human gut due to the potentially involuntary consumption of soil by 
workers at the eight test sites. Many of the USEPA priority PAHs were not bio-accessible from the 
soil. The concentration of the bio-accessible priority USEPA PAHs that were measured is shown in 
Table 2. The bio-accessible fraction expressed as a percentage of the total concentration found is 
also given in the Table. Naphthalene was the most bio-accessible of 16 USEPA PAHs present for 
all the soil samples. Total bio-accessible priority USEPA PAHs for the soils studied ranged between 
0.1% and 41.2% of the total amount (total amount of PAHs in this study was between 689 and 
104,445 ng g-1). In other studies, bio-accessible PAHs varied between 10-60% for soils containing 
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between 10,000-300,000 ng g-1total PAHs (Cave et al.  2010), 0.1-1.4% (Van de Wiele et al.  2004) 
and 1-3% in aged crude oil contaminated soil (Kogel-Knabner et al.  2000). Our study, like others 
(Tao et al.  2009; Cave et al.  2010), showed that only a small fraction of PAHs present in soil is 
bio-accessible to humans. 
Estimation of risk-base on bio-accessible PAHs  
Bio-availability/bio-accessibility is site dependant and source-specific. Since insufficient data has 
been available on bio-accessibility, the default approach of risk assessment is 100% (total 
concentration of PAHs) in calculation. However, for comprehensive work (e.g. remediation, 
allotments among others) a site-specific assessment of bio-accessibility is required for accurate risk 
assessment (Hansen et al.  2007). Sites in this study classified as contaminated or heavily 
contaminated by PAHs were assessed for the risk posed based on their degree of bio-accessibility.  
 
BaPeq of soils base on the bio-accessibility study 
Sum BaPeq dose at different sampling sites in Lagos, Nigeria was between 0.03 (forest soil) and 
16.79 µg g-1 (petroleum product handling site) (Adetunde et al.  2014). A sum BaPeq dose of 0.048 
µg g-1 was found for rural soil from Delhi, India (Agarwal, 2009), 0.892 µg g-1 for roadside soil in 
Shanghai, China (Jiang et al.  2009), 1.009 µg g-1 for traffic dust in Delhi India and 0.650 µg g-1 for 
surface soils in Agra, India (Masih and Taneja, 2006) and 0.124 µg g-1 for soil from Tarragona, 
Spain (Nadal et al.  2004). The dose values found in this study for sites with similar activities were 
lower than those reported by other workers. This may have been as a consequence of the approach 
used. Previous studies used the traditional risk assessment approach which makes use of the total 
concentration PAHs present in the matrices (usually derived from exhaustive extraction techniques). 
The sum BaPeq dose calculations in our study were, based on the bio-accessible PAH(s) 
concentration derived from the FOREShT method, because this is the fraction that poses a health 
risk. The sum BaPeq dose ranged from zero (sites C, F and G) to 0.637 µg g-1 (site B). The sites 
were ordered C, F, G < D, E (0.001 µg g-1) < A (0.002 µg g-1) < H (0.275 µg g-1) < B for the test 
sites (Table 3).  
 
Mean dietary intake of PAHs base on the bio-accessibility study   
Lorenzi et al.  (2011) estimated risk by comparing the MDI for soil with the oral mean daily intake 
threshold for PAHs in food (oral MDI). In our study, a comparison of MDI for the soils (base on the 
concentration of bio-accessible PAHs) with oral MDI for PAHs in food was also undertaken (Table 
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3). The results showed that all the PAHs in composite samples were less than the oral MDI for 
PAHs in food. This indicates that was no risk associated with activities on these sites, based on the 
MDI risk assessment approach.    
 
Cancer estimate of PAHs base on the bio-accessibility data   
The ER results given in Table 3 were based on the bio-accessible PAHs. In this study, the estimated 
total annual daily intake of PAHs will be associated with an ER of 2.5 × 10-09, 6.5 × 10-07, 5.5 × 10-
10, 2.7 × 10-09, 6.5 × 10-10, 9.5 × 10-10, 2.0 × 10-09 and 4.1 × 10-07 for soils A to H respectively; being 
based on a 70 kg adult, exposed at work for 40 years (aged between 25-65 years). The overall 
estimated theoretical cancer risks from occupational exposure to surface soil base on bio-accessible 
oral ingestion were all lower than both the target risk of 1 x 10-06 for normal exposure and the 1 × 
10-04 for extreme exposure all the test sites. The total ER combining the childhood (5 years) and 
adult (40 years) exposure periods was 2.3 × 10-05 based on sum PAHs (ODH 2011). ER values for 
an adult working at the on these sites were between 7.3 × 10-07 and 1.2 × 10-04 according to 
Adetunde et al.  (2014). However, these values were based on the concentration of total 16 priority 
PAHs in soil. Using the concentrations of bio-accessible PAHs, the fraction that causes the actual 
harm, the risk associated with sites in this study where lower (between 4.1 ×10-07 and 9.5 ×10-10 as 
shown in Table 3). 
 
CONCLUSION 
This study assessed potential health risk associated with the bio–assessable PAHs of soils impacted 
by different anthropogenic activities in the Lagos region of Nigeria. Concentrations of the 16 
priority USEPA PAHs were measured and FOREShT an in vitro gastrointestinal model was used to 
extract the bio-accessible PAHs in soils for quantification. Results indicated that though soils from 
sites were classified as heavily contaminated or contaminated, based on their total concentration of 
PAHs, only a percentage (0.7-41.2%) was bio-accessible for uptake by humans. MDI results 
showed that no risk was associated with the bio-accessible fraction of PAHs. The overall cancer risk 
from exposure to surface soil based on oral ingestion was not above the approved health guidelines 
of 1 in 10,000 for extreme exposures. The concentration of bio-accessible PAHs found in our study 
was used to carry out a risk assessment of some soils in the Lagos region of Nigeria. This type of 
approach should now always be used by regulatory agencies when undertaking any comprehensive 
risk assessment of any contaminated land. It must be noted, however, that values derived by this 
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approach only provide a theoretical estimate of risk. Since the actual risk of cancer is unknown and 
it could be as low as zero. PAHs are lipophilic and can accumulate in the body, care should be 
exercised at all times to ensure minimal exposure from all routes to these to these potentially 
harmful substances.   
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Table 1. Concentration (total, ng g-1) of sixteen USEPA priority PAHs found in soil samples 
collected from the Lagos region, Nigeria   
 
Location A B C D E F G H 
PAHs                 
NAP 6,531 675 105 733 1,070 161 308 2,274 
ACY 79.4 2,540 25.3 47.0 8,353 108 2.9 3,843 
ACP 51.1 130 43.1 31.4 640 125 4.3 122 
FLR 142 750 58.4 67.6 1,855 40.9 22.6 652 
PHE 962 17,970 83.5 181.7 86,179 408 107 17,078 
ANT 935 2900 4.8 34.08 84,837 111 56.1 3,945 
FLT 63 4020 13.7 54.2 2,585 320 28.7 5,663 
PYR 242 10,700 30.7 50.7 44,834 246 23.2 6,927 
BaA 216 6,840 36.0 2500 2,054 232 7.4 7,053 
CHR 320 20,110 77.9 15119 11,217 353 35.2 3,982 
BbF 21.0 8,040 28.8 20.5 0 381 17.8 7,453 
BkF 28.5 10,320 35.1 28.9 0 492 23.0 10,202 
BaP 903 3,300 8.2 1,184 0 143 12.3 1,295 
DaH 209 10,040 76.6 425 10,049 330 28.5 10,993 
IcP 34.4 5,790 68.7 87.5 0 657 10.4 4,655 
BgP 1,113 320 6.1 870 249 0 1.3 236 
Sum PAHs 11,850 104,445 702 21,435 253,922 4,108 689 86,373 
 
* Where 0 values correspond to:  ≤ 0.03 µg g-1 for ACY, ≤ 0.04 µg g-1 for FLR, ≤ 0.02 µg g-1 for PHE, ≤ 0.03 µg g-1 for 
ANT, ≤ 0.04 µg g-1 for FLT, ≤ 0.03µg g-1 for PYR, ≤ 0.01 µg g-1 for BaA, ≤ 0.01 µg g-1, for CHR, ≤ 0.0 2µg g-1, for 
BbF, ≤ 0.02 µg g-1, for BkF, ≤ 0.02 µg g-1, for BaP, ≤ 0.04 µg g-1 for DaH, ≤ 0.01 µg g-1 for IcP and ≤ 0.01 µg g-1 for 
BgP. For abbreviations of individual PAHs see Materials and Methods section. 
 
Table 2. Concentration (ng g-1) and percentage* of the bio-accessible priority USEPA PAHs found 
in eight contaminated soil samples (n = 3) collected in the Lagos area, Nigeria. 
*Percentage = Concentration of bio-accessible PAH/Total concentration PAH in soil x 100, LOD = limit of detection, 
nd = not detected. For abbreviations of individual PAHs see Materials and Methods section. 
 
 Soil sample LOD 
Com 
pound  
A B C D E F G H 
 NAP 299±2.3 
(5%) 
92.7±9.15 
(14%) 
90.5±34.5 
(87%) 
327 ± 24.6 
(45%) 
316 ± 132 
(30%) 
100 ± 34.5 
(62%) 
267 ±34.5 
(87%) 
171 ±  8.0 
(8%) 11.6 
ANT 17.6±4.0 (2%) 
29.7±1.2 
(1%) Nd 
28.5 ± 9.8 
(25%) 
40.1 ± 10.0 
(0.1%) 
28.5± 5.4 
(26%) 
17.0 ± 34.5 
(30%) 
26.2 ± 9.0 
(0.7%) 1.6 
BaP nd 
549 ± 3.0 
(17%) Nd nd nd nd Nd 
273 ±  1.56 
(21%) 11.4 
DaH nd 
88.6 ± 55.2 
(0.9%) Nd nd nd nd D nd 20.0 
BgP 194 ± 6.4 (17%) nd Nd nd nd nd Nd 
101 ±  2.8 
(43%) 18.8 
Sum bio-
accessi 
ble  PAH 
511 ± 4.2 
(4.3%) 
760 ± 23.0 
(0.7%) 
91.5 ±35.0 
(12.9%) 
356 ± 15.0 
(1.7%) 
356 ± 100 
(0.1%) 
129 ± 12.9 
(3.1%) 
284 ± 30.0 
(41.2%) 
570 ± 18.0 
(0.9%) 
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Table 3. Bio-accessibility data for test soils and associated MDI (mg day-1), Da(BaPeq) (mg kg-1 day-
1) and ER based on bio-accessible PAHs, BaPeq dose (µg g-1).   
MDI 
A B C D E F G H  aOral MDI   
food 
NAP 0.030 0.009 0.009 0.033 0.032 0.010 0.027 0.017 7 
ACY 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.14 
ACP 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.98 
FLR 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.59 
PHE 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 1.54 
ANT 0.002 0.003 0.000 0.003 0.004 0.003 0.002 0.003 0.08 
FLT 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.35 
PYR 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.35 
BaA 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.06(0.05)
b 
CHR 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.11 
BbF 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.11 
BkF 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.09 
BaP 0.000 0.055 0.000 0.000 0.000 0.000 0.000 0.027 0.11 
DaH 0.000 0.009 0.000 0.000 0.000 0.000 0.000 0.000 0.1 
BgP 0.019 0.000 0.000 0.000 0.000 0.000 0.000 0.010 0.04 
IcP 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.06 
MDI of sum bio-
accessible PAHs 0.051 0.076 0.009 0.036 0.036 0.013 0.028 0.057   
Sum BaPeq dose 0.002 0.637 0.000 0.001 0.001 0.000 0.000 0.275  
 
Da(BaPeq) sum bio-
accessible PAHs 
3.39 
× 10-07 
8.83 
× 10-05 
7.5 × 
10-08 
3.67 × 
10-07 
8.96 × 
10-08 
1.3 
x 10-07 
2.7 × 
10-07 
5.59 × 
10-05   
 
ER based on bio-
accessible PAHs 
2.5 × 
10-09 
6.5 × 
10-07 
5.5 
× 10-10 
2.7 × 
10-09 
6.5 × 
10-10 
9.5 × 
10-10 
2.0 x 
10-09 
4.1 ×  
10-07   
aOral mean daily intake threshold for PAHs in food (oral MDI) (Nathaniel et al.  2009: cited by Lorenzi et al.  [22], 
bAlternative measure of oral MDI (Falco et al.  2003). A value of 0.000 µg g-1 MDI for individual PAH, means that the 
concentration of the bio-accessible PAH less than or equal to the LOD value in Table 3. Benzo(a)pyrene equivalence 
dose (BaPeq), mean daily intake (MDI), Annual daily exposure dose  base on benzo(a)pyrene equivalence dose Da(BaPeq). 
For abbreviations of individual PAHs see Materials and Methods section. 
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Figure 1: Map of soil sampling locations in Lagos, Nigeria. Key to locations: A = Dump site near 
Onike canal, Mainland area, B = Depot/loading point for black oil, Iganmu/Orile, Apapa, C = 
Motor spirit/kerosene depot, Apapa, D = Dump site, Akoka, Mainland area, E = Motor 
spirit/kerosene depot, Coconut Island, F = Roadside, central Lagos, G = Trailer park/mechanics 
workshop, Ibafo, Obafemi Owode and H = Mechanics workshop, Mainland area. 
 
 
Figure 2: Percentage recovery (n = 4) of the 16 USEPA priority PAHs spiked (5,000 ng/mL) into 
the FOREShT saponification extract (1 mL) and subsequently extracted on a C18 Bond Elut solid-
phase extraction cartridge and analysed by the definitive GC/MS method. 
 
   
 
